Northwest Kidney Centers competitors

Joseph 'Joe' Carlucci is a Board Member at Colorado Cntr Reproductive Med, CEO/Co-Founder at American Renal Holdings Inc, and Board Member at American Renal Holdings Inc. He has worked as Chairman/CEO/Co-Founder at AMERICAN RENAL ASSOCIATES HOLDINGS, INC.; COO/Treasurer/Co-Founder at American Renal Holdings Inc; and COO/Treasurer/Co-Founder at AMERICAN RENAL ASSOCIATES HOLDINGS, INC.. Joseph works or has worked as President/CEO at Optimal Renal Care. He studied at Bentley University.

William Valle leads the globally operating Care Delivery segment, in which the company is combining its global healthcare services business effective January 1, 2022. Previously, he served as Chief Executive Officer for North America since February 17, 2017. Prior to that, he was Executive Vice President responsible for the dialysis service business and vascular access business of Fresenius Medical Care North America from 2014 to 2017. Bill joined Fresenius Medical Care in 2009 and has more than 30 years of experience in the dialysis industry, holding executive positions in sales, marketing and business development at several dialysis companies including Gambro Healthcare, Inc.

Jeffrey Goffman is the CEO of Satellite Healthcare a National leading Kidney care company dedicated to making life better for those living with Kidney disease. Satellite has more than 85 locations across 5 states and provides in-center & home dialysis, a CVS Kidney partnership, clinical research & CKD care management focused on improving the quality and access to home dialysis care, reducing costs and implementing integrated value-based care. Goffman is the Vice Chairman of OneGI a Webster Equity portfolio company that is a gastroenterology management services organization that partners with GI physicians to help them manage, optimize & grow their practices and focus on providing excellent care to their patients. Goffman was the CEO of Integrated Oncology Network, LLC (“ION”) which he co-founded in 2008 until 2019. ION is a national oncology company that provides management services to its physician and hospital partners. ION owns more than 50 oncology centers across 17 states in partnership with approximately 300 physicians and 20 hospitals including some of the most prestigious healthcare systems in the US. Goffman was the CEO and Founder of OnCURE Medical Corp. (“OnCURE”) from its inception in 1998 until 2006 when it was sold. OnCURE was private equity sponsored and one of the largest providers of outpatient radiation oncology care in the United States with 40 centers owned and managed and affiliated with more than 100 physicians. Goffman was the CEO of U.S. Diagnostic, Inc. (“USD”), a leading consolidator of diagnostic imaging facilities. Goffman took USD public in 1994, and from inception until 1997 Goffman grew USD to 120 centers inGoffman is an inactive licensed Certified Public Accountant, member of the American Institute of Certified Public Accountants, and holds a Bachelor of Science degree in Accounting from the Barney School of Business at the University of Hartford. Goffman was inducted into the Barney School of Business Alumni Hall of Fame in 2014. Goffman is a member of the board of directors of several non-profit organizations including the American Cancer Society’s CEO’s Against Cancer and CureDuchenne.

Mark Caputo is the Chairman of the Board and Chief Executive Officer of U.S. Renal Care. Mark has spent the majority of his career building dialysis organizations focused on partnerships. Before joining U.S. Renal Care, Mark founded Liberty Dialysis in 2002 and served as its Chief Executive Officer, growing the business from a single clinic to the third-largest dialysis provider in the world, with 260 dialysis clinics serving 20,000 patients. In 2012, Liberty Dialysis merged with Fresenius Medical Care. Following the merger, Mark served as Managing Partner of Joint Ventures for Fresenius Medical Care, and then Chairman of the Board of Sound Physicians until June 2018. During his tenure as Chairman, Sound Physicians employed more than 3,500 hospital medicine physicians in 200 hospitals around the country. Mark received his M.B.A. from Harvard Business School and B.A. in Economics from Princeton University.

James L. Madara, MD, serves as the CEO and executive vice president of the American Medical Association, the nation’s largest physician organization. He holds the academic title of adjunct professor of pathology at Northwestern University. Since taking the reins of the AMA in 2011, Dr. Madara has helped sculpt the organization’s visionary long-term strategic plan. As an extension of this vision, he now also serves as chairman of Health2047 Inc., an independent, design-driven innovation firm based in San Francisco whose mission is to help advance the AMA’s goal of improving the health of the nation. Prior to arriving at the AMA, Dr. Madara spent the first 22 years of his career at Harvard Medical School, receiving both clinical and research training, serving as a tenured professor and as director of the NIH-sponsored Harvard Digestive Diseases Center. Following 5 years as chair of pathology at Emory, Dr. Madara served as dean of the medical school and CEO of the hospitals at the University of Chicago, bringing together the university’s biomedical research, teaching and clinical activities. While there, he oversaw the renewal of the institution’s biomedical campus and engineered significant new affiliations with community hospitals, teaching hospital systems, community clinics and national research organizations. Dr. Madara also served as senior advisor with Leavitt Partners, an innovative health care consulting and private-equity firm founded by former Secretary of Health and Human Services, Mike Leavitt. Having published more than 200 original papers and chapters, Dr. Madara has received both national and international awards, and served as editor-in-chief of the American Journal of Pathology and as president of the American Board of Pathology. In addition to Modern Healthcare consistently naming him as one of the nation’s 50 most influential physician executives, as well as one of the nation’s 100 most influential people in health care, he is a past recipient of a prestigious MERIT Award from the National Institutes of Health. He received the 2011 Davenport Award for lifetime achievement in gastrointestinal disease from the American Physiological Society and the 2011 Mentoring Award for lifetime achievement from the American Gastroenterological Society. Dr. Madara is an elected member of both the American Society of Clinical Investigation and the Association of American Physicians. He also co-chairs the Value Incentives and Systems Innovation Collaborative of the National Academy of Medicine (NAM), and is a member of NAM’s Leadership Consortium for Value & Science-Driven Health Care. Dr. Madara and his wife Vicki have 2 children, Max and Alexis.

With years of clinical leadership experience, Dr. Kevin Klauer brings valuable and innovative talents to the team. Dr. Klauer is a proven leader and brings his expertise and knowledge to the company as the chief medical officer for Emergency Medicine, chief risk officer for TeamHealth, and executive director of TeamHealth’s Patient Safety Organization. He works hard to develop cutting-edge patient safety and clinical best practices throughout the organization and directs clinical risk management. Dr. Klauer is responsible for: • risk management initiatives • clinical education • litigation support • patient safety • assistance with training medical directors • promotion of effective communication with physicians and advanced practice clinicians Concurrent with his role at TeamHealth, Dr. Klauer is an assistant clinical professor at Michigan State University College of Osteopathic Medicine and serves as the medical editor-in-chief for ACEP Now, the monthly publication of the American College of Emergency Physicians (ACEP). He previously served as editor-in-chief for Emergency Physicians Monthly. Dr. Klauer has published three risk-management books, Emergency Medicine Bouncebacks: Medical and Legal, Risk Management and the Emergency Department: Executive Leadership and Protecting Patients and Hospitals, with a third, Pediatric Bouncebacks, released in March 2015. Dr. Klauer also served as a speaker of the ACEP Council. Dr. Klauer received the ACEP National Teaching Faculty Award in 2001 and the Emergency Medicine Resident's Association Robert Dougherty ACEP/Emergency Medicine Foundation Teaching Fellowship. In 2014, he was the recipient of ACEP's Honorable Mention Outstanding Speaker of the Year Award and was recognized by the Ohio Chapter of ACEP with the Bill Hall Award of Service. Dr. Klauer earned his Executive Juris Doctor with honors from Concord Law School in 2011.

Paul Abramowitz is a Chief Executive Officer at American Society for Health-System Pharmacists.